---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-045447"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2026-10-02T13:25:23+00:00"
generated_at: "2026-10-12T14:33:16.143510+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Hepion raises authorized common stock to 750,000,000 shares via Delaware Certificate of Amendment

## Summary
- Certificate of Amendment filed with the Delaware Secretary of State and effective October 1, 2026, increased Hepion's authorized common stock to 750,000,000 shares.
- The filing does not state the prior authorized share count, the reason for the increase, or any planned issuance, financing or pricing terms tied to the new shares.
- Full text of the Certificate of Amendment is attached as Exhibit 3.1; the 8-K is signed by Interim CEO Gary Stetz and dated October 2, 2026.
- Hepion's common stock (HEPA) is quoted on the OTC QB; no change to par value of $0.0001 per share was disclosed.

## SEC filing metadata
- accession: 0001493152-26-045447
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2026-10-02T13:25:23+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000149315226045447/0001493152-26-045447-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000149315226045447/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-045447
- JSON: https://secwatch.observer/filing/0001493152-26-045447.json
- Plain text: https://secwatch.observer/filing/0001493152-26-045447.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.